Literature DB >> 10436442

Serum amylase isoenzymes in patients undergoing operation for ruptured and non-ruptured abdominal aortic aneurysm.

D J Adam1, A A Milne, S M Evans, J E Roulston, A J Lee, C V Ruckley, A W Bradbury.   

Abstract

OBJECTIVE: Previous work has suggested that hyperamylasemia in patients who undergo operation for ruptured abdominal aortic aneurysm (AAA) is associated with poor outcome. The aims of this study were to determine, for the first time, the source of serum amylase in such patients and to examine the prognostic significance of amylase isoenzyme expression.
METHODS: This study was designed as a prospective clinical and laboratory study. The study consisted of 40 patients who underwent operation for ruptured AAA and 10 patients who underwent operation for non-ruptured AAA. The main outcome measures were serum total and pancreatic and salivary amylase activities determined with enzymatic colorimetric assay before operation and 6 hours after aortic clamp release.
RESULTS: Five of 40 patients (12.5%) with rupture and one of 10 patients (10%) with non-rupture had elevated total amylase levels before operation, and seven of 31 patients (23%) with rupture and five of 10 patients (50%) with non-rupture had elevated total amylase levels after operation. The preoperative salivary amylase (P =.05) and postoperative pancreatic amylase (P <.02) levels were significantly lower in ruptured AAA as compared with non-ruptured AAA. The preoperative salivary amylase level was significantly lower in non-survivors of rupture, such that a level equal to or less than 45 U/L was associated with death in 11 of 13 patients (85%).
CONCLUSION: These data do not support previous works that suggest that hyperamylasemia is associated with poor outcome in ruptured AAA. By contrast, a low preoperative salivary amylase level was associated with increased mortality in ruptured AAA and may be a marker of the severity of shock.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10436442     DOI: 10.1016/s0741-5214(99)70132-1

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  10 in total

1.  Need for an Ethical Framework for Testing for Systemic Diseases in Dental Clinics.

Authors:  Marushka Leanne Silveira; Amit Chattopadhyay
Journal:  Ethics Biol Eng Med       Date:  2011-04-01

Review 2.  Saliva: diagnostics and therapeutic perspectives.

Authors:  N Spielmann; D T Wong
Journal:  Oral Dis       Date:  2010-12-02       Impact factor: 3.511

Review 3.  Detection of inflammatory biomarkers in saliva and urine: Potential in diagnosis, prevention, and treatment for chronic diseases.

Authors:  Sahdeo Prasad; Amit K Tyagi; Bharat B Aggarwal
Journal:  Exp Biol Med (Maywood)       Date:  2016-03-24

4.  Salivary enzymes in peptic ulcer disease.

Authors:  Mojdeh Motamedi; Fariborz Mansour-Ghanaei; Reyhaneh Sariri; Mahmoud Vesal
Journal:  J Oral Biol Craniofac Res       Date:  2013-04-05

5.  A soft pancreatic remnant is associated with increased drain fluid pancreatic amylase and serum CRP levels following pancreatoduodenectomy.

Authors:  Yoshiaki Murakami; Kenichiro Uemura; Yasuo Hayasidani; Takeshi Sudo; Yasushi Hashimoto; Naoya Nakagawa; Hiroki Ohge; Taijiro Sueda
Journal:  J Gastrointest Surg       Date:  2007-10-23       Impact factor: 3.452

Review 6.  Saliva: an emerging biofluid for early detection of diseases.

Authors:  Yu-Hsiang Lee; David T Wong
Journal:  Am J Dent       Date:  2009-08       Impact factor: 1.522

7.  Therapeutic strategy using extracorporeal life support, including appropriate indication, management, limitation and timing of switch to ventricular assist device in patients with acute myocardial infarction.

Authors:  Naoyoshi Aoyama; Hiroshi Imai; Toshiro Kurosawa; Naoto Fukuda; Masahiko Moriguchi; Makoto Nishinari; Mototsugu Nishii; Ken Kono; Kazui Soma; Tohru Izumi
Journal:  J Artif Organs       Date:  2013-10-27       Impact factor: 1.731

8.  Salivary Immunoglobulin Gene Expression in Patients with Caries.

Authors:  Gema Regina Guadarrama Santín; Angel Visoso Salgado; Norma Margarita Montiel Bastida; Isaías de la Rosa Gómez; Jonnathan Guadalupe Santillán Benítez; Hugo Mendieta Zerón
Journal:  Open Access Maced J Med Sci       Date:  2017-03-03

9.  Saliva Neurofilament Light Chain Is Not a Diagnostic Biomarker for Neurodegeneration in a Mixed Memory Clinic Population.

Authors:  Helena Sophia Gleerup; Federica Sanna; Peter Høgh; Joel Simrén; Kaj Blennow; Henrik Zetterberg; Steen Gregers Hasselbalch; Nicholas J Ashton; Anja Hviid Simonsen
Journal:  Front Aging Neurosci       Date:  2021-05-10       Impact factor: 5.750

10.  THE ROLE OF NEW TECHNOLOGIES IN DEFINING SALIVARY PROTEIN COMPOSITION FOLLOWING PLACEMENT OF FIXED ORTHODONTIC APPLIANCES - BREAKTHROUGH IN THE DEVELOPMENT OF NOVEL DIAGNOSTIC AND THERAPEUTIC PROCEDURES.

Authors:  Vojka Zgombić Popović; Lovorka Grgurević; Vladimir Trkulja; Ruđer Novak; Dubravka Negovetić-Vranić
Journal:  Acta Clin Croat       Date:  2020-09       Impact factor: 0.780

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.